Edwards Lifesciences Corporation (EW) : Traders are bullish on Edwards Lifesciences Corporation (EW) as it has outperformed the S&P 500 by a wide margin of 12.39% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 7.85%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 7.78% in the last 1 week, and is up 16.17% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 8.41% and the 50-Day Moving Average is 12.34%. Edwards Lifesciences Corp. is up 7.82% in the last 3-month period. Year-to-Date the stock performance stands at 45%.
Edwards Lifesciences Corporation (NYSE:EW): stock turned positive on Friday. Though the stock opened at $113, the bulls momentum made the stock top out at $114.79 level for the day. The stock recorded a low of $112.7 and closed the trading day at $114.52, in the green by 1.35%. The total traded volume for the day was 1,385,289. The stock had closed at $112.99 in the previous days trading.
Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. The Company develops hemodynamic monitoring systems used to measure a patients cardiovascular function in the hospital setting. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by the its Critical Care products. The Companys products and technologies it offers to treat advanced cardiovascular disease are categorized into three main areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.